Israel to accept submissions for registration of biosimilars approved in US and EU
This article was originally published in SRA
Executive Summary
The Israeli Ministry of Health’s Pharmaceutical Administration has announced that it is now accepting the submission of applications for the registration of biosimilar medicinal products that have been approved by either the European Commission, following the recommendation of the European Medicines Agency, or the US Food and Drug Administration1.